iTeos Therapeutics
ITOS
$10.50
Share price
-0.66%
Change (1 day)
-21.76%
Change (1 year)
Categories
iTeos Therapeutics (ITOS) - P/B ratio
P/B ratio as of April 2024 : 0.6586
According to iTeos Therapeutics's latest financial reports the company has a price-to-book ratio of 0.6586.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
iTeos Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.6812 | -34.96% |
| 2022-12-31 | 1.05 | -64.74% |
| 2021-12-31 | 2.97 | -18.99% |
| 2020-12-31 | 3.67 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | 268.86% | 🇺🇸 USA |